Exam 4 New Material PDF

Summary

This document provides an overview of terminology, types of pathogens, disease progression stages and methods of transmission. It also covers pathogen survival mechanisms, host defense evasion, toxins and damage, and identification methods.

Full Transcript

Terminology Host → larger organism supporting pathogenic microorganism growth Infection → microbe growth/multiplication on/within host, may or may not cause disease Infectious disease → health state change due to pathogen presence Pathogen → disease causing organism Pathogenicity → disease-causing a...

Terminology Host → larger organism supporting pathogenic microorganism growth Infection → microbe growth/multiplication on/within host, may or may not cause disease Infectious disease → health state change due to pathogen presence Pathogen → disease causing organism Pathogenicity → disease-causing ability (scale) Virulence → degree of harm caused to host Infectivity → ability to create a discrete point of infection Invasiveness → ability to spread to adjacent tissues Active penetration → lytic substances that alter host tissue Passive penetration → does not relate to pathogen itself (lesions or wounds) Types of Pathogens Extracellular → remain in tissue/fluids without entering host cells Intracellular → grow within host cells, -​ Facultative intracellular pathogen → can grow inside or outside host cells -​ Obligate intracellular pathogen → can grow only inside the host cells Disease Progression Stages 1.​ Incubation period → time between entry and symptom (subjective; pain) development 2.​ Prodromal stage → mild, non-specific symptoms 3.​ Illness period → Most severe stage; peak symptoms 4.​ Convalescence → recovery stage Methods of transmission Airborne → droplets (talking near someone), droplet nuclei (indirect - remain airborne for a while), dust particles Contact → direct (person to person) or indirect (fomites; door handle) Vehicle → surgical materials, food/water, biological materials - indirectly transmit pathogens Vector-borne → arthropods or vertebrates (highly virulent - do not harm vector) Vertical → mother to fetus -​ Pathogen’s virulence may be influenced by its ability to live outside its host -​ Exposure alone is not enough for infection to occur → tropism; determined by specific cell surface receptors Pathogen Survival Mechanisms 1.​ Protection from host defenses 2.​ Nutrient acquisition 3.​ Energy utilization 4.​ Adhesion mechanisms a.​ pili/fimbriae b.​ membrane/capsule materials c.​ Specialized adhesion molecules Host Defense Evasion 1.​ Biofilm formation 2.​ Immune system suppression 3.​ Capsule production → avoid phagocytosis 4.​ Genetic adaptation 5.​ Cell surface protein modification Phage variation → a reversible bacterial process that facilitates rapid genetic changes in response to changing environment Toxins and Damage Toxin → substance that disrupts the normal metabolism of host cells Toxigenicity → pathogen’s ability to produce toxins Intoxications → disease that results from entry of a specific preformed toxin into host Exotoxin → secreted proteins; site of infection into other body tissues or cells -​ Most lethal; encoded by genes on plasmids or prophages -​ Soluble, Heat labile -​ AB toxins → inhibition of protein synthesis → cell death -​ Clathrin dependent -​ pH 5 → dissociates A from B -​ A → catalyze toxicity reaction - NAD+ and EF-2 → Nicotinamide + ADP → inhibit protein synthesis -​ B → binds to host cell receptor → B recycled and dissociation from binding site when returned to surface -​ Membrane-destabilizing toxins → change osmolarity by forming pores on membrane -​ Superantigens → overstimulation of adaptive immune system -​ T cell overexpression (CD4 - MHC II)→ cytokines → pro-inflammation -​ Local effects Endotoxin -​ Heat stable -​ O-antigen in LPS of gram-negative bacteria - bound to bacteria and released when microorganism lyses -​ System effects → effect entire body rather than a single tissue or organ Mycotoxin -​ Produced by fungi -​ Common food crop contaminants -​ Cause liver disease and cancer Infectious dose 50 (ID50) → amount needed to infect 50% of hosts Lethal dose 50 (LD50) → amount needed to kill 50% of hosts Identification Methods Culture based methods -​ Selective → antibiotic plate supplemented for a specific type of bacteria -​ differential media → multiple organisms but able to differentiate between them -​ Hemolysis → patterns on blood agar -​ Gamma → no change -​ Alpha → partial breakdown -​ Beta → complete breakdown Immunomagnetic Based Technology -​ Antibody-coated magnetic particles to isolate specific microbes -​ Enabling pure culture isolation from mixed populations → only those with antibody attachment will be isolated with magnet - the rest is washed -​ Reduces contamination and increases accuracy Rapid identification systems -​ API 20E system → 20 biochemical tests -​ Identification code → automated systems (database for identification) Fungi identification → different from bacteria -​ Cultures → recover fungus from specimen -​ Evaluate growth rate and appearance on one selective and non-selective agar medium -​ Colonial morphology, color and dimorphism examined Microscopy -​ Wet Mount, heat or chemical fixation -​ Gram staining - peptidoglycan identification for appropriate antibiotic therapy -​ Fluorescence microscopy → visualization with fluorochrome staining Immunological Methods Immunofluorescence -​ Direct → uses fluorochrome-labeled antibodies directly on specimen - presence or absence of pathogen -​ Indirect → uses patient serum followed by labeled secondary antibodies - presence or absence of antibodies (secondary antibodies bind to) Molecular detection -​ PCR → DNA amplification -​ Real-time PCR → quantitative analysis -​ Ribotyping → bacterial identification using 16s rRNA -​ DNA fingerprinting for strain differentiation Serological Testing Serotyping → used to differentiate between strains (serotypes) that have different antigenic compositions of a structure or product Agglutination Test -​ Blood typing and syphilis detection -​ Viral hemagglutination assays -​ Blood + measles virus → hemagglutination -​ Measles virus + antibodies from patient serum + blood → virus is neutralized due to antibody binding → inhibition of hemagglutination -​ Complement fixation tests for antibody detection Elisa -​ Direct (antigen trapped between two antibodies)→ detect protein antigens + protein enzyme = color change to yellow -​ Indirect (HIV testing) → detect antibodies → comparison between patient and control → indicator visualizes if there are antibodies attached to antigen = change color for positive results -​ Visualization → chromogen Lateral Flow assays → filter paper contains antigen -​ Test line → antibodies bind to antigen -​ Control line → excess antibody without antigen Western blot → protein analysis → lyme disease -​ Protein separation by electrophoresis -​ Primary and secondary antibodies → visualize amount of protein Flow cytometry → cell population → HIV monitoring (CD4+ and CD8+) -​ Fluorescently labeled stained cells + laser light = cell size and quantity Enveloped viruses can integrate their genome into host’s DNA (i.e. HIV) Non-enveloped - enter, replicate and lyse (i.e. poliovirus) Airborne Transmission → spread through respiratory droplets - cough, sneeze or speaking Chickenpox (varicella) → highly infectious DNA virus (uses host machinery to replicate viral genome) -​ Early genes → replication of viral genome -​ Late genes → transcription for assembly proteins - maturation -​ Preventable or shortening of illness from vaccine -​ Previous contraction = antibodies Shingles (herpes zoster) → reactivation of dormant chickenpox virus in cranial nerves -​ Vaccine available for individuals over 50 years -​ Immunocompromised person → virus migrates down sensory nerves → visual and auditory impairment COVID-19 → +RNA virus (direct translation of proteins) -​ Viral response phase → flu-like symptoms -​ Inflammatory response phase (cytokine storm) → shortness of breath, poor gas exchange -​ Mutations increase transmission not virulence -​ Higher risk for elderly, overweight and type II diabetics Influenza (A, B and C) → -RNA (replication needed for template mRNA translation) - lytic cycle by release of virions from infected cells -​ Viral particles → respiratory epithelium → nucleocapsid released into cytosol -​ Antigenic drift → small mutations -​ Antigenic shift → major changes Measles (Membrane - envelope) → -RNA *enveloped* -​ Red lesions (Koplik’s spots) -​ Progressive denaturation of CNS -​ Symptoms → fever, whooping cough, headache and conjunctivitis -​ MMR vaccine only - NO treatment Mumps (mumps virus - membrane) → -RNA *enveloped* -​ Transmission through saliva and respiratory droplets → swelling and tenderness of salivary glands (weeks after infection) -​ No cure just control symptoms -​ Pleomorphic (shape morphing) -​ Transmission through saliva and respiratory droplets Rubella (german measles) - enveloped +RNA -​ Red spot rash appears as immunity develops -​ Congenital rubella syndrome → vertical transmission → fetal death -​ MMR vaccine Smallpox (orthopox virus) → dsDNA -​ Malaise, body aches, high fever -​ Small red bumps filled with fluid -​ eradicated through vaccination Arthropod-borne Disease → fevers with/without rash, encephalitis and hemorrhagic fevers Dengue Fever → enveloped +RNA -​ 4 serotypes -​ Antibody-dependent enhancement (previous infection with different DENV) -​ Opsonize virus and hijack immune system West Nile Virus (flavivirus) → +RNA -​ Encephalitis -​ Mosquitoes that fed in infected birds -​ No treatment or vaccine Zika → enveloped +RNA -​ Can be transmitted person to person through bodily fluids (breastmilk or semen) -​ Birth Defects → microcephaly Direct Contact Transmission AIDS by HIV → Retrovirus (reverse transcriptase) HIV → bodily fluid transmission (blood, semen, vaginal secretions or breastmilk) -​ Viral protein attachment (gp120) → facilitates attachment to host cells -​ Macrophage infection → CCR5 → cross BBB -​ T-cell infection → CXCR-4 -​ Can integrate into host cell DNA and remain latent (asymptomatic) -​ Medication → suppress transcription of viral genome -​ Replication occurs in lymphoid tissue -​ T-helper cell reduction → opportunistic infections begin → CNS disease Cytomegalovirus (CMV) → enveloped dsDNA -​ Herpesviridae family -​ Can infect any cell of the body → cell swelling Genital Herpes → enveloped dsDNA -​ Active and latent disease with reactivations Mononucleosis (Epstein-Barr virus) → enveloped dsDNA -​ Mature virion → linear -​ Latent form → circular -​ Infect B cells -​ symptomatic/supportive therapy Hepatitis → infection and inflammation of liver -​ A-E → fecal oral transmission -​ HEP B → enveloped dsDNA -​ Dane particle → mature virion Food and Waterborne Diseases Poliomyelitis → +RNA (enterovirus) -​ Infantile paralysis -​ nearly eradicated by vaccination -​ Multiplies in throat and small intestine -​ When persistent → enters CNS → paralytic polio Viral Gastroenteritis → food poisoning -​ Stomach and intestinal inflammation -​ F-O transmission -​ Norovirus -​ Rotavirus - vaccination Zoonotic Diseases Ebola → -RNA -​ Transmission through bodily fluids -​ Vector - bats -​ Viral hemorrhagic fever - vascular damage - blood blisters -​ No standard treatment - vaccination Rabies → -RNA -​ Neurotropic virus -​ Enters NS through acetylcholine receptors - clathrin dependent -​ Utilizes host ribosomes to translate viral proteins → negri bodies → spinal cord -​ Progressive encephalitis Diagnosis → Immunofluorescent antibody, serology for antibody or PCR Treatment → pre and post vaccination

Use Quizgecko on...
Browser
Browser